Nektar Therapeutics (NKTR) — Defensive Interval Ratio
Nektar Therapeutics (NKTR) has a Defensive Interval Ratio of 2785 days as of March 2026. Defensive assets of $440.34 Million (cash $-, short-term investments $436.74 Million, receivables $3.60 Million) cover 2785 days of daily cash needs of $158.10K/day. Check NKTR tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Nektar Therapeutics Defensive Interval Ratio (1997–2025)
This chart shows how Nektar Therapeutics's Defensive Interval Ratio has evolved across 29 annual periods from 1997 to 2025. As of March 2026, the ratio stands at 2785 days, meaning defensive assets of $440.34 Million can fund 2785 days of operations without new revenue. Also explore Nektar Therapeutics (NKTR) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Nektar Therapeutics (1997–2025)
The table below presents the year-by-year Defensive Interval Ratio for Nektar Therapeutics from 1997 to 2025, covering 29 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see NKTR company net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1585 days | $232.41 Million | $146.67K/day | $- | $230.64 Million | ▲ +321 days |
| 2024 | 1264 days | $212.58 Million | $168.22K/day | $- | $210.97 Million | ▼ -663 days |
| 2023 | 1926 days | $270.59 Million | $140.46K/day | $- | $268.34 Million | ▼ -349 days |
| 2022 | 2275 days | $425.15 Million | $186.86K/day | $- | $416.75 Million | ▼ -857 days |
| 2021 | 3133 days | $731.23 Million | $233.42K/day | $- | $708.74 Million | ▲ +290 days |
| 2020 | 2843 days | $901.83 Million | $317.20K/day | $- | $862.94 Million | ▲ +1538 days |
| 2019 | 1305 days | $1.27 Billion | $969.57K/day | $- | $1.23 Billion | ▼ -3964 days |
| 2018 | 5269 days | $1.18 Billion | $224.66K/day | $- | $1.14 Billion | ▲ +3342 days |
| 2017 | 1926 days | $296.38 Million | $153.87K/day | $- | $291.37 Million | ▲ +182 days |
| 2016 | 1744 days | $345.14 Million | $197.87K/day | $- | $329.46 Million | ▲ +115 days |
| 2015 | 1629 days | $273.32 Million | $167.80K/day | $- | $253.37 Million | ▲ +323 days |
| 2014 | 1305 days | $229.07 Million | $175.47K/day | $- | $225.46 Million | ▲ +562 days |
| 2013 | 744 days | $200.19 Million | $269.10K/day | $- | $197.96 Million | ▼ -453 days |
| 2012 | 1197 days | $257.56 Million | $215.17K/day | $- | $251.76 Million | ▲ +891 days |
| 2011 | 306 days | $230.79 Million | $754.88K/day | $- | $225.86 Million | ▼ -1535 days |
| 2010 | 1841 days | $323.28 Million | $175.64K/day | $- | $298.18 Million | ▲ +1002 days |
| 2009 | 838 days | $351.42 Million | $419.22K/day | $- | $346.61 Million | ▼ -414 days |
| 2008 | 1252 days | $234.57 Million | $187.33K/day | $- | $223.41 Million | ▼ -339 days |
| 2007 | 1591 days | $427.70 Million | $268.75K/day | $- | $406.06 Million | ▲ +615 days |
| 2006 | 976 days | $442.03 Million | $452.92K/day | $- | $394.88 Million | ▼ -194 days |
| 2005 | 1170 days | $223.13 Million | $190.67K/day | $- | $214.93 Million | ▼ -975 days |
| 2004 | 2146 days | $327.17 Million | $152.47K/day | $- | $314.33 Million | ▲ +369 days |
| 2003 | 1777 days | $228.07 Million | $128.38K/day | $- | $221.92 Million | ▲ +266 days |
| 2002 | 1510 days | $263.46 Million | $174.42K/day | $- | $259.09 Million | ▼ -450 days |
| 2001 | 1961 days | $318.03 Million | $162.19K/day | $- | $313.54 Million | ▼ -2342 days |
| 2000 | 4303 days | $356.06 Million | $82.75K/day | $- | $348.83 Million | ▲ +2753 days |
| 1999 | 1550 days | $106.51 Million | $68.71K/day | $- | $104.75 Million | ▼ -108 days |
| 1998 | 1658 days | $57.95 Million | $34.95K/day | $- | $57.95 Million | ▼ -160 days |
| 1997 | 1818 days | $85.22 Million | $46.89K/day | $- | $85.22 Million | — |